PuSH - Publication Server of Helmholtz Zentrum München

134 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
41.
Roblek, M.* et al.: Targeting of CCL2-CCR2-glycosaminoglycan axis using a CCL2 decoy protein attenuates metastasis through inhibition of tumor cell seeding. Neoplasia 18, 49-59 (2016)
42.
Saito, Y.* et al.: Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice. Blood 128, 1829-1833 (2016)
43.
Scherr, A.L.* et al.: Bcl-xL is an oncogenic driver in colorectal cancer. Cell Death Dis. 7:e2342 (2016)
44.
Spinner, S.* et al.: Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance. Leukemia 30, 1520-1530 (2016)
45.
Sunami, Y.* et al.: Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR. Hepatology 63, 1592-1607 (2016)
46.
Sunami, Y.* et al.: Canonical NF-kappa B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 63, 1, 233A-233A (2016)
47.
Weber, A.* & Heikenwälder, M.: P(URI)fying novel drivers of NASH and HCC: A feedforward loop of IL17A via white adipose tissue. Cancer Cell 30, 15-17 (2016)
48.
Wolf, B.* et al.: Inducing differentiation of premalignant hepatic cells as a novel therapeutic strategy in hepatocarcinoma. Cancer Res. 76, 5550-5561 (2016)
49.
Berger, E.* et al.: Mitochondrial dysfunction impairs epithelial proliferative control and stemness in the intestinal crypts. J. Crohns Colitis 9, S104 (2015)
50.
Borst, K.* et al.: In virus-induced hepatitis local IFN-I responses modulate myeloid suppressor cell infiltration. Cytokine 76, 108 (2015)
51.
Boutaffala, L.* et al.: NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis. Cell Death Differ. 22, 2020-2033 (2015)
52.
Dargel, C. et al.: T cells engineered to express a T-cell receptor specific for glypican-3 to recognize and kill hepatoma cells in vitro and in mice. Gastroenterology 149, 1042-1052 (2015)
53.
Endig, J.* et al.: CD8+ T-cells drive liver injury and hepatocellular carcinoma in chronic liver disease. Hepatology 62, 1244A (2015)
54.
Finkin, S.* et al.: Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat. Immunol. 16, 1235-1244 (2015)
55.
Friemel, J.* et al.: Intratumor heterogeneity in hepatocellular carcinoma. Clin. Cancer Res. 21, 1951-1961 (2015)
56.
Garnelo, M.* et al.: Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut 66, 342-351 (2015)
57.
Goldmann, T.* et al.: USP18 lack in microglia causes destructive interferonopathy of the mouse brain. EMBO J. 34, 1612-1629 (2015)
58.
Herranz, N.* et al.: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17, 1205-1217 (2015)
59.
Jors, S.* et al.: Lineage fate of ductular reactions in liver injury and carcinogenesis. J. Clin. Invest. 125, 2445-2457 (2015)
60.
Michler, T.* et al.: RNAi-based gene therapy for chronic hepatitis B: Evaluation in a murine model. L. J. Hepatol. 62, S526 (2015)